Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-11-3
pubmed:abstractText
Thymidylate synthase (TS1), RRM1, and ERCC1, which are crucial for DNA synthesis and repair and have shown prognostic and predictive value in carcinomas, were investigated in Ewing/primitive neuroectodermal tumor (PNET). The tissue microarray consisting of 31 archived Ewing/PNET samples was subjected to immunohistochemistry based on immunofluorescence combined with automated quantitative analysis (AQUA) to assess in-situ expression. Automated quantitative analysis score was analyzed with various clinicopathologic data. TS1 was immunoreactive in the nucleus and cytoplasm, while RRM1 and ERCC1 were nuclear. High TS1 expression, not RRM1 and ERCC1, was associated with long overall survival (p value = 0.057). Thus in-situ TS1 protein expression in Ewing/PNET is a prognostic marker.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1551-3823
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
385-92
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Thymidylate synthase 1 (TS1) in-situ protein expression predicts the survival of Ewing/PNET.
pubmed:affiliation
Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612-9497, USA. Marilyn.Bui@moffitt.org
pubmed:publicationType
Journal Article